TeleWellnessMD®
We love our First Responders!
All Active Military, Military Veterans, First Responders & Law Enforcement get 10% off all orders.
Just our way of saying thank you!
Select your time!
My Account
US-Licensed Medical Providers & Pharmacies
Tirzepatide/BPC-157 Continuation Vial (4.5mL Vial)
Peptides
Weight Management
Health & Wellness
Key Benefits:Tirzepatide/BPC-157
Subcutaneous injection
6 Week Supply
Requires telehealth consult
Not available in AL, CA, IA, KY, MS, NM, WI, AK, AZ, AR, CO, CT, DE, DC, FL, GA, HI, ID, IN, LA, KS, MD, MA, MI, ME, MN, MO, MT, NV, NE, NH, NJ, NY, NC, ND, OH, OK, IL, PA, PR, RI, SC, SD, TN, OR, VA, WA, VT, WV, UT, WY or TX
Tirzepatide (also known as Mounjaro) is a peptide therapy for the treatment of type 2 diabetes and has also been found effective in supporting weight management.
Brent Agin MD
01/18/2024 3:23PM
Similar to Semaglutide, Tirzepatide works by increasing insulin sensitivity, improving glucose metabolism and decreasing appetite.
Studies have shown that chronic inflammation can be a contributing factor of obesity and weight gain which is why Tirzepatide has been combined with BPC-157.
Tirzepatide vs. Semaglutide
Tirzepatide and Semaglutide are medications in the same class and have both been approved for the treatment of type 2 diabetes. Semaglutide has recently been FDA approved for the treatment of weight management, while Tirzepatide has received Fast Track designation.
Tirzepatide has a unique, dual action approach with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist properties. This combination of actions is thought to have a greater impact on weight loss compared to Semaglutide, which only affects the GLP-1 receptor.
Some studies have shown Tirzepatide to be more effective in promoting weight loss than Semaglutide, with one study showing patients lost an average of 14.9% of their body weight on Tirzepatide while others on Semaglutide lost an average of 10.4%.
Tips for Taking Tirzepatide/BPC-157: You can take Tirzepatide/BPC-157 with or without food. If you need to change the day of the week, you may do so if your last dose of Tirzepatide/BPC-157 was given 2 or more days before. What to Do if You Miss a Dose: If you miss a dose of Tirzepatide/BPC-157 and the next scheduled dose is more than 2 days away (>48 hours), take the missed dose as soon as possible. If you miss a dose of Tirzepatide/BPC-157 and the next scheduled dose is less than 2 days away (<48 hours), do not administer the dose. Take your next dose on the regularly scheduled day. Who Should NOT Take Tirzepatide/BPC-157: If you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). If you have had a serious allergic reaction to Tirzepatide/BPC-157.
Potential Benefits
Safety Information
Important Information:
Tips for Taking Tirzepatide/BPC-157: You can take Tirzepatide/BPC-157 with or without food. If you need to change the day of the week, you may do so if your last dose of Tirzepatide/BPC-157 was given 2 or more days before. What to Do if You Miss a Dose: If you miss a dose of Tirzepatide/BPC-157 and the next scheduled dose is more than 2 days away (>48 hours), take the missed dose as soon as possible. If you miss a dose of Tirzepatide/BPC-157 and the next scheduled dose is less than 2 days away (<48 hours), do not administer the dose. Take your next dose on the regularly scheduled day. Who Should NOT Take Tirzepatide/BPC-157: If you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). If you have had a serious allergic reaction to Tirzepatide/BPC-157.
Ingredients:
Tirzepatide/BPC-157 16.6mg/0.5mg/mL